Abstract 4357798: Risk assessment in primary prevention: plaque matters most

W Warren Skoza (CNIC, Madrid, Spain) D Dylan Taylor B Belen de Cortes Oliva Pellicer (CNIC, Madrid, Spain) S Stuart Pocock (Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid) C Carlos Galan (CNIC, Madrid, Spain) A Ana Devesa S Sadiya Khan (Northwestern University, Chicago, Illinois, United States) M Michael Shapiro (Wake Forest Univ School of Medicine, Winston Salem, North Carolina, United States) J Javier Sanchez-Gonzalez (Philips HealthCare, Madrid, Spain) I Ines Garcia-Lunar (CNIC, Madrid, Spain) A Ana Garcia Alvarez (CNIC, Madrid, Spain) V Valentín Fuster B Borja Ibañez

Abstract

Background: Cardiovascular disease (CVD) risk stratification in primary prevention involves risk factor-based calculators. Subclinical atherosclerosis (SA) disease burden represents an individualized signature of cumulative risk factor exposure and may be undervalued in traditional assessment. Research Questions: How do risk calculators perform for predicting SA surrogates in healthy participants? Can a simplified risk score incorporating SA burden compete with conventional risk factor-based calculators? Methods: Asymptomatic participants in the Progression of Early Subclinical Atherosclerosis (PESA) and BioImage cohorts underwent assessment of ultrasound (US) plaque presence/progression and coronary artery calcium (CAC) presence, which were analyzed as binary surrogate outcomes of atherosclerosis. The performance of various calculators was compared using C-statistics in each cohort overall, by sex, and by age tertiles. A simplified novel risk score utilizing age, sex, and US plaque burden was developed in the BioImage cohort for predicting 5-year major adverse cardiovascular events (MACE; all-cause death, stroke, myocardial infarction, or coronary revascularization). Comparisons were drawn with established risk scores using C-statistics. Results: The cohorts had distinct characteristics (PESA n=3588, median age 46 years, 36% female; BioImage n=6011, median age 69 years, 57% female). All scores were moderately accurate for SA presence by US and CAC, though performance diminished with age (see Table). Scores were less accurate for predicting SA progression in either cohort. In the BioImage cohort, 473 MACE were observed at 5 years. Estimates of 5-year risk increased with age, with increasing baseline plaque burden, and with male sex (see Figure). Performance of the novel calculator using only age, sex, and plaque burden was significantly better than traditional risk factor-based scores (C-statistic 0.667, see Table). Conclusion: In two large cohorts of healthy participants with distinct age ranges, risk factor-based calculators predict SA surrogates with similar accuracy to their prediction of cardiovascular outcomes. A novel simplified score derived from 3 variables (age, sex, plaque burden) outperformed several contemporary risk factor-based calculators. Incorporating SA burden may improve a precision medicine approach to the primary prevention of CVD.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (13)

W

Warren Skoza

CNIC, Madrid, Spain

D

Dylan Taylor

B

Belen de Cortes Oliva Pellicer

CNIC, Madrid, Spain

S

Stuart Pocock

Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid

C

Carlos Galan

CNIC, Madrid, Spain

A

Ana Devesa

S

Sadiya Khan

Northwestern University, Chicago, Illinois, United States

M

Michael Shapiro

Wake Forest Univ School of Medicine, Winston Salem, North Carolina, United States

J

Javier Sanchez-Gonzalez

Philips HealthCare, Madrid, Spain

I

Ines Garcia-Lunar

CNIC, Madrid, Spain

A

Ana Garcia Alvarez

CNIC, Madrid, Spain

V

Valentín Fuster

B

Borja Ibañez